譜尼測試(300887.SZ):在化粧品檢測領域,具備CMA、CNAS等資質
格隆匯2月2日丨譜尼測試(300887.SZ)在投資者互動平台表示,公司是國家藥監局認可的化粧品註冊和備案檢驗機構,在化粧品檢測領域,具備CMA、CNAS等資質,多次承擔國家級、省級政府主管部門的監督抽檢和風險監測任務,併為京東、天貓等電商平台提供質量監督服務。可開展產品註冊備案檢測、風險物質檢測、人體功效評價、毒理實驗、產品型式檢驗、產品安全評估、化粧品原料檢測等檢測項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.